Tetracaine Raw Material Powder Treatment For Premature Ejaculation CAS:94-24-6
Tetracaine hydrochloride, a crystalline white powder, stands as a cornerstone in the pantheon of local anesthetics, renowned for its exceptional potency and prolonged duration of action. As a raw material, it represents the pure, unformulated active pharmaceutical ingredient (API) that serves as the foundational component for compounded and manufactured anesthetic preparations. Its role in medicine, while specialized, is critical in scenarios demanding profound and sustained nerve blockade. This comprehensive analysis delves into the essence of tetracaine powder, exploring its characteristics, mechanisms, applications, and critical handling parameters.
What is Tetracaine Raw Material Powder?
Tetracaine HCl (chemical name: 2-(Dimethylamino)ethyl 4-(butylamino)benzoate hydrochloride) is an ester-class local anesthetic. In its raw material form, it is a fine, white, odorless, crystalline powder that is highly soluble in water and alcohol. This solubility is paramount for its formulation into various pharmaceutical delivery systems. As an API, its purity is strictly governed by pharmacopeial standards (such as USP/NF or Ph. Eur.), ensuring it is free from impurities and contaminants that could affect efficacy or safety. It is a synthesis-derived compound, not extracted from natural sources, and its molecular structure is optimized for high lipid solubility, a key determinant of its potent anesthetic properties.
Distinguishing Features and Mechanism of Action
Tetracaine's profile is defined by several key features that differentiate it from other local anesthetics like lidocaine or bupivacaine:
1.High Potency: Tetracaine is approximately 8-10 times more potent than procaine and significantly more potent than lidocaine. This high intrinsic activity means effective anesthesia can be achieved with relatively lower concentrations of the drug at the target site.
2.Long Duration of Action: It provides one of the longest durations of sensory blockade among local anesthetics. Its effects can persist for up to 3-4 hours, or even longer when used in spinal anesthesia, owing to its high protein-binding capacity which slows systemic absorption and clearance from the neuronal environment.
3.High Lipid Solubility: This property allows tetracaine to readily diffuse through the lipid-rich neuronal membrane, facilitating rapid access to its site of action within the sodium channels of the nerve axon.
4.Ester-Linkage Metabolism: As an ester-type anesthetic, tetracaine is rapidly hydrolyzed in the blood by plasma pseudocholinesterase. This is a critical safety feature, as it generally limits systemic toxicity. However, individuals with a genetic deficiency of this enzyme (atypical pseudocholinesterase) are at a significantly heightened risk of toxic accumulation.
Mechanism of Action: Tetracaine exerts its effect by reversibly binding to specific voltage-gated sodium channels on the inner side of the neuronal membrane. This binding inhibits the conformational changes necessary for channel activation. By preventing sodium ion influx, tetracaine halters the initiation and propagation of the action potential. The nerve membrane becomes stabilized and unable to depolarize, leading to a complete blockade of sensory (and to a lesser extent, motor) nerve transmission.
Applications and Clinical Benefits
The use of tetracaine raw material is almost exclusively in professional medical settings due to its high potency and associated risk profile. Its primary applications are:
1.Spinal Anesthesia (Subarachnoid Block): This is the most significant application for tetracaine. Formulated as a heavy solution (often in dextrose), it is injected into the cerebrospinal fluid to achieve surgical anesthesia for procedures below the umbilicus, such as lower abdominal, pelvic, rectal, and lower extremity surgeries. Its long duration makes it ideal for prolonged operations.
2.Topical Anesthesia: Tetracaine is a key component in various topical formulations, including creams, gels, and ophthalmic solutions. Its high potency allows for effective surface anesthesia. Notably, it is used in:
○Ophthalmology: For procedures like tonometry, cataract removal, and corneal foreign body removal.
○Otolaryngology: To anesthetize the mucous membranes of the nose, pharynx, and larynx prior to endoscopic examinations.
○Dermatology: In compounded creams for minor dermatological procedures.
3.Infiltration and Nerve Block Anesthesia: While less common due to the availability of safer alternatives like lidocaine and bupivacaine, tetracaine can be used for peripheral nerve blocks. Its use is often in combination with a shorter-acting agent to accelerate onset while maintaining a long duration.
The primary benefit of tetracaine is its ability to provide profound and long-lasting anesthesia from a single administration. This is invaluable in spinal anesthesia for lengthy surgeries, reducing the need for repeated dosing or conversion to general anesthesia. Its efficacy as a topical agent provides excellent patient comfort for otherwise painful superficial procedures.
Dosage, Cycle, and Half-Life
The handling of tetracaine powder requires extreme precision. Dosages are meticulously calculated in milligrams and are highly dependent on the route of administration, the type of block desired, and patient-specific factors (age, weight, health status).
●Spinal Anesthesia: Typical doses range from 5 mg to 20 mg. The specific dose is carefully titrated based on the desired height and duration of the block. For example, a 10-15 mg dose may provide anesthesia for 1.5-2.5 hours for a perineal procedure.
●Topical Application: Concentrations for ophthalmic use are typically 0.5%, while solutions for mucous membranes can range from 1% to 2%. The total dose must be monitored to avoid systemic absorption.
Cycle (Onset and Duration):
●Onset of Action: The onset for spinal anesthesia is relatively rapid, within a few minutes. Topical application on mucous membranes may take 1-2 minutes for full effect. Its onset is slower than that of lidocaine.
●Duration of Action: This is tetracaine's hallmark. Spinal blocks can last 2-3 hours, with full recovery taking several hours more. Topical anesthesia lasts for a sufficient duration to complete most procedures.
Half-Life:
The plasma half-life of tetracaine is very short, estimated to be less than 1 minute in individuals with normal pseudocholinesterase enzyme levels. This is because it is hydrolyzed so rapidly in the bloodstream to para-aminobenzoic acid (PABA) and other metabolites. However, the functional half-life (the duration of effect at the nerve site) is prolonged due to its high tissue binding and slow release from the neuronal environment. This disconnect between plasma half-life and clinical effect is a crucial pharmacokinetic characteristic.
PTC (Percutaneous Toxicity Concentration) and Critical Safety Considerations
While the term "Percutaneous Toxicity Concentration" (PTC) is not a standard, universally defined pharmacologic parameter like LD50, it can be interpreted in the context of tetracaine's significant systemic toxicity risk.
Tetracaine has a very narrow therapeutic index. Its high potency means that the margin between an effective dose and a toxic dose is small. Systemic toxicity primarily affects the Central Nervous System (CNS) and the Cardiovascular System (CVS).
●CNS Toxicity: Manifests as initial excitation (nervousness, dizziness, tremors, seizures) followed by depression (respiratory arrest, coma).
●CVS Toxicity: Results in myocardial depression, severe hypotension, bradycardia, and potentially cardiac arrest. Cardiovascular collapse can occur without preceding CNS symptoms, especially with potent agents like tetracaine.
Therefore, the "safe concentration" for any formulation, especially topical, is paramount. For topical solutions, concentrations are kept low (e.g., 1-2%), and application to highly vascular areas or large broken skin surfaces is avoided to prevent rapid absorption. The total dose for topical use should be minimized.
This underscores why tetracaine raw material is not for consumer or amateur use. It is a substance that demands respect, handled only by qualified professionals (anesthesiologists, pharmacists, surgeons) who understand its pharmacokinetics, can calculate safe dosages, and are equipped to manage life-threatening toxic reactions immediately. The ready availability of lipid emulsion therapy as an antidote for local anesthetic systemic toxicity (LAST) is a mandatory safety prerequisite in any setting where tetracaine is used.
Clinical Data
|
Trade names |
Tetracaine, amethocaine,Pontocaine, Ametop, Dicaine |
|
CAS |
94-24-6 |
|
Molar mass |
264.37 |
|
MF |
C15H24N2O2 |
|
Purity |
Above 98% |
|
Apprarance |
White Crystalline Powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion
Tetracaine hydrochloride raw material powder is not a first-line anesthetic for every procedure, but a powerful specialized tool in the medical arsenal. Its identity is defined by unparalleled potency and longevity, making it indispensable for spinal anesthesia and potent topical formulations. Its value is coupled with a formidable risk profile, necessitating stringent handling, precise dosing, and vigilant patient monitoring. Its rapid metabolic clearance is a built-in safety mechanism that is only effective within the bounds of proper clinical use. Ultimately, tetracaine exemplifies a principle of pharmacology: the most effective tools are often the ones that demand the utmost respect and expertise.
Hot Tags: tetracaine raw material powder treatment for premature ejaculation cas:94-24-6, China tetracaine raw material powder treatment for premature ejaculation cas:94-24-6 manufacturers, suppliers, factory, Superdrol, Tadalafil, Testosterone Cypionate, Testosterone Enanthate, Testosterone Isocaproate manufacturers, Trenbolone Acetate
